Isocitrate Dehydrogenase 1 Inhibitor
- Name
- Isocitrate Dehydrogenase 1 Inhibitor
- Accession Number
- DBCAT005866
- Description
Not Available
- Drugs
Drug Drug Description Ivosidenib An isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation. - Drugs & Drug Targets
Drug Target Type Ivosidenib Isocitrate dehydrogenase [NADP] cytoplasmic target Ivosidenib Cytochrome P450 3A4 enzyme Ivosidenib Cytochrome P450 2B6 enzyme Ivosidenib Cytochrome P450 2C9 enzyme Ivosidenib Cytochrome P450 2C8 enzyme Ivosidenib Solute carrier family 22 member 8 transporter Ivosidenib P-glycoprotein 1 transporter